UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Sickle cell disease; a general overview

Netherlands journal of medicine, 2004-11, Vol.62 (10), p.364-374

2004

Volltextzugriff (PDF)

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

BJC Reports, 2024-06, Vol.2 (1), p.1-4, Article 45

2024

Volltextzugriff (PDF)

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

Annals of hematology, 2005-05, Vol.84 (5), p.282-286

2005

Volltextzugriff (PDF)

An unusual craving

Netherlands journal of medicine, 2015-02, Vol.73 (2), p.96

2015

Volltextzugriff (PDF)

Protein C and S and inflammation in sickle cell disease

American journal of hematology, 2004-05, Vol.76 (1), p.26-32

2004

Volltextzugriff (PDF)

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

Blood cells, molecules, & diseases, 2010-04, Vol.44 (4), p.229-232

2010

Volltextzugriff (PDF)

Elevated IL-8 levels during sickle cell crisis

European journal of haematology, 1998-11, Vol.61 (5), p.302-305

1998

Volltextzugriff (PDF)

Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study

American journal of hematology, 2001-11, Vol.68 (3), p.179-183

2001

Volltextzugriff (PDF)

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Haematologica (Roma), 2008-05, Vol.93 (5), p.e42-e44

2008

Volltextzugriff (PDF)

Steady-state sVCAM-1 serum levels in adults with sickle cell disease

Annals of hematology, 2003-02, Vol.82 (2), p.109-113

2003

Volltextzugriff (PDF)

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

Annals of hematology, 2003-03, Vol.82 (3), p.171-174

2003

Volltextzugriff (PDF)

Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease

Clinical immunology (Orlando, Fla.), 2000-09, Vol.96 (3), p.264-268

2000

Volltextzugriff (PDF)

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease

American journal of hematology, 2002-09, Vol.71 (1), p.53-55

2002

Volltextzugriff (PDF)

Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib

American journal of hematology, 2008-09, Vol.83 (9), p.757-758

2008

Volltextzugriff (PDF)

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Acta haematologica, 2008-01, Vol.120 (3), p.130-133

2008

Volltextzugriff (PDF)

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Acta haematologica, 2009-01, Vol.122 (1), p.64-69

2009

Volltextzugriff (PDF)

Folate status assessment and folic acid supplements in sickle cell disease

Journal of pediatric hematology/oncology, 2001-11, Vol.23 (8), p.548-548

2001

Volltextzugriff (PDF)

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Journal of pediatric hematology/oncology, 2000-03, Vol.22 (2), p.184-185

2000

Volltextzugriff (PDF)

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Haematologica (Roma), 2008-05, Vol.93 (5), p.757-760

2008

Volltextzugriff (PDF)

Sickle cell patients are characterized by a reduced glycocalyx volume

Haematologica (Roma), 2008-02, Vol.93 (2), p.307-308

2008

Volltextzugriff (PDF)

Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients

American journal of hematology, 1998-11, Vol.59 (3), p.192-198

1998

Volltextzugriff (PDF)

New concepts in assessing sickle cell disease severity

American journal of hematology, 1998-05, Vol.58 (1), p.61-66

1998

Volltextzugriff (PDF)

An unusual craving

The Netherlands journal of medicine, 2015, Vol.73 (2), p.96-96

2015

Volltextzugriff (PDF)

An analytical view of the BJH publication of ‘a clinician's view of voxelotor’

British journal of haematology, 2023-03, Vol.200 (6), p.e56-e57

2023

Volltextzugriff (PDF)

An urgent call to raise the bar in oncology

British journal of cancer, 2021-11, Vol.125 (11), p.1477-1485

2021

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(56)
Berichte
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(43)
Hematology
(37)
Adult
(30)
Female
(28)
Male
(26)
Anemia, Sickle Cell - Blood
(25)
Middle Aged
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Hematologic And Hematopoietic Diseases
(20)
Sickle Cell Disease
(20)
Anemias. Hemoglobinopathies
(19)
Diseases Of Red Blood Cells
(19)
Anemia, Sickle Cell - Complications
(15)
Young Adult
(10)
Adolescent
(8)
Anemia, Sickle Cell - Physiopathology
(8)
Vascular Cell Adhesion Molecule-1 - Blood
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sickle cell disease; a general overview

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

An unusual craving

Protein C and S and inflammation in sickle cell disease

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

Elevated IL-8 levels during sickle cell crisis

Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Steady-state sVCAM-1 serum levels in adults with sickle cell disease

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease

Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Folate status assessment and folic acid supplements in sickle cell disease

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Sickle cell patients are characterized by a reduced glycocalyx volume

Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients

New concepts in assessing sickle cell disease severity

An unusual craving

An analytical view of the BJH publication of ‘a clinician's view of voxelotor’

An urgent call to raise the bar in oncology

Aktive Filter

Suchergebnisse filtern